Surgical Treatment of Pulmonary Aspergilloma

نویسندگان

  • Elham Lotfian Biologist, research expert, Lung disease Research Center, Emam Reza hospital, Mashhad university of medical science, Mashhad, Iran
  • Reza Afghani Thoracic Surgeon, department of general surgery, 5th of Azar Hospital, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
  • Reza Bagheri Thoracic Surgeon, Lung disease Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Saeed Hakimian Medical student, Mashhad University of Medical Science, Mashhad, Iran
  • Seyed ziaollah Haghi Thoracic Surgeon, Lung disease Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Vahab Azmounfar Medical student, Student Research Committee, Faculty of medicine, Mashhad university of medical science, Mashhad, Iran
چکیده مقاله:

Introduction: Surgical approaches for the management of pulmonary aspergilloma have been accompanied with high levels of morbidity and mortality. However, these therapeutic options are still favored over other approaches for the treatment of Pulmonary Aspergilloma. In this study, we aimed to describe the characteristics of 30 patients with aspergilloma who referred to  Ghaem hospital between 2017-2018 and describe their results. Materials and Methods: This retrospective study was conducted on 30 patients (i.e., 21 males and 9 females) with pulmonary aspergilloma who were treated via surgery. The patients were examined based on their age, gender, clinical symptoms prior to surgery, affected pulmonary lobe, surgical method, and postoperative complications. Results: The mean age of the patients was 48.13(5.2) years. Hemoptysis (90%) was the most common symptom of pulmonary aspergilloma, followed by productive cough and drug-resistant pneumonia. The most common problematic lobes included left upper lobe and right upper lobe. Regarding the surgical method, 21 and 9 patients underwent lobectomy and segmentectomy, respectively. After the surgery, residual space, wound infection, ad bronchopleural fistula was observed in 5 (16.7%), 3 (10%), and 2 (6.7%) cases, respectively. Furthermore, only one patient passed away. Conclusion: As the findings indicated, the methods of surgery (i.e., lobectomy and segmentectomy) showed effective treatment for patients.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Surgical treatment of pulmonary aspergilloma.

The objective of this study was to analyze the outcome of surgical treatment of pulmonary aspergilloma. To that end, we evaluated 14 adult patients so treated between 1981 and 2009 at the Botucatu School of Medicine University Hospital, in the city of Botucatu, Brazil. Data were collected from the medical records of the patients. Ten patients (71%) presented with simple pulmonary aspergilloma, ...

متن کامل

Surgical treatment for pulmonary aspergilloma – early and long-term results

INTRODUCTION Pulmonary aspergilloma is a difficult therapeutic problem due to the low effectiveness of conservative treatment and high surgical morbidity. AIM To analyze the early and late results of surgical treatment for pulmonary aspergilloma. MATERIAL AND METHODS From 2005 to 2015, 49 patients were treated surgically for pulmonary aspergilloma. Symptoms occurred in 85.7% of cases, inclu...

متن کامل

Surgical treatment for pulmonary aspergilloma: a 28 year experience.

BACKGROUND Pulmonary aspergilloma has been treated surgically for many years but the mortality rates of larger surgical series, varying from 7% to 23%, is not considered acceptable by today's standards. The authors report their experience in the surgical treatment of pulmonary aspergilloma and present a review of the literature. METHODS Sixty seven patients who underwent thoracotomy for pulmo...

متن کامل

Treatment of pulmonary aspergilloma with itraconazole.

In a 12 month open study of itraconazole in pulmonary aspergilloma nine patients received oral itraconazole 200 mg daily for six months followed by further itraconazole or observation for a further six months. There was no change in the serum IgG specific for Aspergillus fumigatus (mean (SE) change -4% (10%)) or symptoms of chronic cough and haemoptysis. In two of the three patients who continu...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}


عنوان ژورنال

دوره 7  شماره 1

صفحات  413- 416

تاریخ انتشار 2019-03-01

با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023